BL0020
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BL0020, covering 2026-02-17 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer [Phase 1]